Showing 1-10 of 14 grants

Title Institution Researcher Program Duration Total Award Amount
Platforms for Cross-Therapeutic Profiling and Mechanistic Studies of Immune-Modifying Therapies in Type 1 Diabetes Benaroya Research Institute at Virginia Mason Dan Campbell Cures 01-March-2026 to 28-February-2029 $1.045.621,50
Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells Pluristyx Benjamin Fryer Cures 15-November-2025 to 14-November-2027 $704.860,20
Thermally responsive minimally invasive proangiogenic placeholder for cell transplantation for Type 1 Diabetes University of Washington Patrick Stayton Cures 01-November-2025 to 31-October-2028 $894.965,96
microRNAs as regulators of stem cell differentiation into islet cells University of Washington Vincenzino Cirulli Cures 01-August-2025 to 31-July-2027 $600.000,00
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) University of Washington Petter Bjornstad Improving Lives 01-September-2025 to 31-August-2028 $2.040.014,30
Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics University of Washington Petter Bjornstad Improving Lives 01-June-2024 to 30-November-2025 $488.511,63
Long-read approaches to identify coding, non-coding, and structural variation that contributes to T1D risk Benaroya Research Institute at Virginia Mason Eddie James Cures 01-September-2024 to 28-February-2026 $150.000,00
Achieving Health in Emerging Adults with Diabetes Program Seattle Childrens Hospital Faisal Malik Improving Lives 01-September-2024 to 31-August-2028 $672.941,74
Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators University of Washington Vincenzino Cirulli Cures 01-October-2024 to 30-September-2026 $500.000,00
Assessing and mitigating T cell recognition of iPSC derived endocrine cells in Type 1 Diabetes Benaroya Research Institute at Virginia Mason Eddie James Cures 01-June-2024 to 31-May-2026 $500.000,00